IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v15y2018i7p1539-d159009.html
   My bibliography  Save this article

Study of the In Vitro Antagonistic Activity of Various Single-Strain and Multi-Strain Probiotics against Escherichia coli

Author

Listed:
  • Sabina Fijan

    (Faculty of Health Sciences, University of Maribor, Žitna ulica 15, 2000 Maribor, Slovenia)

  • Dunja Šulc

    (Faculty of Health Sciences, University of Maribor, Žitna ulica 15, 2000 Maribor, Slovenia)

  • Andrej Steyer

    (Faculty of Medicine, Institute of Microbiology and Immunology, University of Ljubljana, Zaloška 4, 1000 Ljubljana, Slovenia)

Abstract

Escherichia coli is an important commensal of our gut, however, many pathogenic strains exist, causing various severe infections in the gut or beyond. Due to several antibiotic resistance patterns of E. coli , research of alternative treatments or adjuvant therapy is important. One of these is the use of probiotics as antagonistic agents against E. coli . Most published studies investigate only one strain of E. coli and single-strain probiotics. The objectives of this study were to evaluate the antagonistic activity of selected single-strain and multi-strain probiotic supplements against selected clinical E. coli pathotypes using the in vitro agar spot test and the co-culturing method. Molecular methods were used to determine the presence of the genus lactobacilli and bifidobacteria as well as certain selected strains in the probiotic supplements. The agar-spot test showed that the multi-strain probiotics were more effective than the single-strain probiotics. On the other hand, the co-culturing method showed the opposite result, indicating that results are importantly influenced by the chosen method. The most effective single-strain probiotics against E. coli strains were Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus reuteri DSM 17938. The most effective multi-strain probiotics contained lactobacilli, bifidobacteria and enterococci strains, thus proving that most effective probiotics against E. coli strains are the lactic acid bacteria and bifidobacteria. The overall results from both in vitro tests reveal that all selected probiotics exhibited an antagonistic activity against all E. coli strains. From a public health perspective probiotics have thus proved to be successful in inhibiting the growth of E. coli and could therefore be used as adjuvant therapy or alternative therapy in E. coli infections.

Suggested Citation

  • Sabina Fijan & Dunja Šulc & Andrej Steyer, 2018. "Study of the In Vitro Antagonistic Activity of Various Single-Strain and Multi-Strain Probiotics against Escherichia coli," IJERPH, MDPI, vol. 15(7), pages 1-15, July.
    • Handle: RePEc:gam:jijerp:v:15:y:2018:i:7:p:1539-:d:159009
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/15/7/1539/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/15/7/1539/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Raphael S. Steinberg & Lilian C. S. Silva & Tássia C. Souza & Maurício T. Lima & Nayara L. G. De Oliveira & Leda Q. Vieira & Rosa M. E. Arantes & Anderson Miyoshi & Jacques R. Nicoli & Elisabeth Neuma, 2014. "Safety and Protective Effectiveness of Two Strains of Lactobacillus with Probiotic Features in an Experimental Model of Salmonellosis," IJERPH, MDPI, vol. 11(9), pages 1-22, August.
    2. Mokaba Shirley Malema & Akebe Luther King Abia & Roman Tandlich & Bonga Zuma & Jean-Marc Mwenge Kahinda & Eunice Ubomba-Jaswa, 2018. "Antibiotic-Resistant Pathogenic Escherichia Coli Isolated from Rooftop Rainwater-Harvesting Tanks in the Eastern Cape, South Africa," IJERPH, MDPI, vol. 15(5), pages 1-14, May.
    3. Sabina Fijan, 2014. "Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature," IJERPH, MDPI, vol. 11(5), pages 1-23, May.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Sabina Fijan & Anita Frauwallner & László Varga & Tomaž Langerholc & Irena Rogelj & Mateja Lorber & Peter Lewis & Petra Povalej Bržan, 2019. "Health Professionals’ Knowledge of Probiotics: An International Survey," IJERPH, MDPI, vol. 16(17), pages 1-16, August.
    2. repec:zib:zibwcm:v:7:y:2023:i:1:p:55-59 is not listed on IDEAS

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Mario Giordano & Maria Elisabetta Baldassarre & Viviana Palmieri & Diletta D. Torres & Vincenza Carbone & Luisa Santangelo & Federico Gentile & Raffaella Panza & Federica Di Mauro & Manuela Capozza & , 2019. "Management of STEC Gastroenteritis: Is There a Role for Probiotics?," IJERPH, MDPI, vol. 16(9), pages 1-8, May.
    2. Sabina Fijan & Anita Frauwallner & László Varga & Tomaž Langerholc & Irena Rogelj & Mateja Lorber & Peter Lewis & Petra Povalej Bržan, 2019. "Health Professionals’ Knowledge of Probiotics: An International Survey," IJERPH, MDPI, vol. 16(17), pages 1-16, August.
    3. Martina O. Chukwu & Akebe Luther King Abia & Eunice Ubomba-Jaswa & Lawrence Obi & John Barr Dewar, 2019. "Characterization and Phylogenetic Analysis of Campylobacter Species Isolated from Paediatric Stool and Water Samples in the Northwest Province, South Africa," IJERPH, MDPI, vol. 16(12), pages 1-22, June.
    4. Lidia Stasiak-Różańska & Anna Berthold-Pluta & Antoni Stanisław Pluta & Krzysztof Dasiewicz & Monika Garbowska, 2021. "Effect of Simulated Gastrointestinal Tract Conditions on Survivability of Probiotic Bacteria Present in Commercial Preparations," IJERPH, MDPI, vol. 18(3), pages 1-17, January.
    5. Noreddine Benkerroum, 2019. "Retrospective and Prospective Look at Aflatoxin Research and Development from a Practical Standpoint," IJERPH, MDPI, vol. 16(19), pages 1-47, September.
    6. Ashok J. Tamhankar & Cecilia Stålsby Lundborg, 2019. "Antimicrobials and Antimicrobial Resistance in the Environment and Its Remediation: A Global One Health Perspective," IJERPH, MDPI, vol. 16(23), pages 1-7, November.
    7. Anna Zawistowska-Rojek & Tomasz Zaręba & Stefan Tyski, 2022. "Microbiological Testing of Probiotic Preparations," IJERPH, MDPI, vol. 19(9), pages 1-19, May.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:15:y:2018:i:7:p:1539-:d:159009. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.